Chemerin has been proposed as a pro-inflammatory marker in multiple sclerosis, due to its function as a chemoattractant for inflammatory cells (Lande et al. 2008; Graham et al. 2009). This evidence concerns the gene RARRES2 and multiple sclerosis.